Further Companies Confirm Canadian Revlimid Rivals
Apotex And Sandoz Are Also Among Competitors To Have Launched Lenalidomide
Executive Summary
Further launches of generic lenalidomide rivals to Celgene’s Revlimid have been confirmed in Canada by Apotex and Sandoz.
You may also be interested in...
Lenalidomide Launch Kicks Off A Year Of Revlimid Competition
Accord has confirmed the launch of a generic lenalidomide rival to Revlimid in the UK. The launch leads off a year that is expected to see the BMS blockbuster also face significant competition elsewhere in Europe and the US.
Accord’s UK Lenalidomide Launch Kicks Off A Year Of Revlimid Competition
Accord has confirmed the launch of a generic lenalidomide rival to Revlimid in the UK. The launch leads off a year that is expected to see the BMS blockbuster also face significant competition elsewhere in Europe and the US.
Dr Reddy’s Eyes Generic Revlimid Exclusivity With ANDA Approval
With Natco poised to debut the first batch of Revlimid generics in the US in March next year, fellow Indian ANDA sponsor Dr Reddy’s Laboratories has secured its own approval from the FDA for two strengths of the blockbuster multiple myeloma treatment.